Search Results - "Punter, Rosa Mar Gómez"

Refine Results
  1. 1

    Desaturations During 6-Minute Walk Test and Predicting Nocturnal Desaturations in Adult Subjects With Cystic Fibrosis by Gómez Punter, Rosa Mar, Girón Moreno, Rosa M, Vázquez Espinosa, Emma, Soriano, Joan B, Pastor, M Teresa, Zamora, Enrique, Valenzuela, Claudia, Alonso, Tamara, García Castillo, Elena, Ancochea, Julio

    Published in Respiratory care (01-01-2019)
    “…Nocturnal desaturation in cystic fibrosis (CF) may have prognostic implications because a significant and maintained nocturnal desaturation can contribute to…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Is Obesity a Problem in New Cystic Fibrosis Treatments? by Solís-García, Marta, García-Clemente, Marta María, Madrid-Carbajal, Claudia Janeth, Peláez, Adrián, Gómez Punter, Rosa Mar, Eiros Bachiller, Jose María, Girón Moreno, Rosa María

    Published in Nutrients (01-09-2024)
    “…Malnutrition has always been a problem in CF (cystic fibrosis) patients; however, new treatments with CFTR (cystic fibrosis transmembrane conductance regulator…”
    Get full text
    Journal Article
  4. 4

    Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review by Girón Moreno, Rosa María, García-Clemente, Marta, Diab-Cáceres, Layla, Martínez-Vergara, Adrián, Martínez-García, Miguel Ángel, Gómez-Punter, Rosa Mar

    Published in Antibiotics (Basel) (23-04-2021)
    “…Cystic fibrosis (CF) is a genetic disease that causes absence or dysfunction of a protein named transmembrane conductance regulatory protein (CFTR) that works…”
    Get full text
    Journal Article
  5. 5

    Longitudinal Study of Therapeutic Adherence in a Cystic Fibrosis Unit: Identifying Potential Factors Associated with Medication Possession Ratio by Girón, Rosa Mª, Peláez, Adrián, Ibáñez, Amparo, Martínez-Besteiro, Elisa, Gómez-Punter, Rosa Mar, Martínez-Vergara, Adrián, Ancochea, Julio, Morell, Alberto

    Published in Antibiotics (Basel) (01-11-2022)
    “…Cystic fibrosis (CF) is a genetic and multisystemic disease that requires a high therapeutic demand for its control. The aim of this study was to assess…”
    Get full text
    Journal Article
  6. 6

    Long-term safety and efficacy of tobramycin in the management of cystic fibrosis by Vázquez-Espinosa, Emma, Girón, Rosa María, Gómez-Punter, Rosa Mar, García-Castillo, Elena, Valenzuela, Claudia, Cisneros, Carolina, Zamora, Enrique, García-Pérez, F Javier, Ancochea, Julio

    Published in Therapeutics and clinical risk management (01-01-2015)
    “…Cystic fibrosis (CF) is a fatal inherited disease caused by mutations in the CF transmembrane conductance regulator (CFTR) gene whose mortality is conditioned…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    New evidence in severe pneumonia: imipenem/ cilastatin/relebactam by Girón, R M, Ibáñez, A, Gómez-Punter, R M, Alarcón, T

    Published in Revista española de quimioterapia (01-04-2022)
    “…Imipenem combined with beta-lactamase inhibitor relebactam (IMI/REL) has an extensive bactericidal activity against Gram-negative pathogens producing class A…”
    Get full text
    Journal Article
  13. 13

    Presence of anxiety and depression in patients with bronchiectasis unrelated to cystic fibrosis by Girón Moreno, Rosa María, Fernandes Vasconcelos, Gilda, Cisneros, Carolina, Gómez-Punter, Rosa Mar, Segrelles Calvo, Gonzalo, Ancochea, Julio

    “…INTRODUCTIONPatients with chronic bronchiectasis (BQ) may suffer from psychological disorders. The objective of this study was to assess the presence of…”
    Get full text
    Journal Article
  14. 14

    Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis by Girón-Moreno, Rosa Maria, Justicia, José L, Yamamoto, Sara, Valenzuela, Claudia, Cisneros, Carolina, Gómez-Punter, Rosa Mar, Fernandes-Vasconcelos, Gilda, Ancochea, Julio

    Published in BMC pulmonary medicine (23-09-2014)
    “…Pulmonary exacerbation is one of the main risk factors for death in patients with cystic fibrosis. Several biomarkers have proven useful in the diagnosis and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Presence of Anxiety and Depression in Patients With Bronchiectasis Unrelated to Cystic Fibrosis by Girón Moreno, Rosa María, Fernandes Vasconcelos, Gilda, Cisneros, Carolina, Gómez-Punter, Rosa Mar, Segrelles Calvo, Gonzalo, Ancochea, Julio

    “…Abstract Introduction Patients with chronic bronchiectasis (BQ) may suffer from psychological disorders. The objective of this study was to assess the presence…”
    Get full text
    Journal Article
  17. 17

    Inhaled antibiotic therapy in cystic fibrosis by Girón Moreno, Rosa M, Salcedo Posadas, Antonio, Mar Gómez-Punter, Rosa

    “…Cystic fibrosis is the most frequent fatal genetically-transmitted disease among Caucasians. Chronic bronchial infection, especially by Pseudomonas aeruginosa,…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Trastornos psicológicos y calidad de vida en pacientes con bronquiectasias no relacionadas con fibrosis quística by Girón Moreno, Rosa María, Fernandes Vasconcelos, Gilda, Cisneros, Carolina, Gómez-Punter, Rosa Mar, Segrelles Calvo, Gonzalo, Ancochea, Julio

    Published in Archivos de bronconeumología (01-10-2013)
    “…Resumen Introducción Los pacientes con bronquiectasias (BQ), como enfermos crónicos, pueden verse afectados por trastornos psicológicos. El objetivo del…”
    Get full text
    Journal Article
  20. 20